PD-118057
CAS No. 313674-97-4
PD-118057 ( PD 118057 | PD118057 )
产品货号. M14010 CAS No. 313674-97-4
一种有效的选择性 hERG 钾通道 (Kv11.1) 激活剂,可将 HEK293 细胞中 10 uM 的峰值尾部 hERG 电流增加 111.1%。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥2043 | 有现货 |
|
| 10MG | ¥3126 | 有现货 |
|
| 25MG | ¥4910 | 有现货 |
|
| 50MG | ¥6752 | 有现货 |
|
| 100MG | ¥8811 | 有现货 |
|
| 200MG | ¥11880 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥1739 | 有现货 |
|
生物学信息
-
产品名称PD-118057
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述一种有效的选择性 hERG 钾通道 (Kv11.1) 激活剂,可将 HEK293 细胞中 10 uM 的峰值尾部 hERG 电流增加 111.1%。
-
产品描述A potent, selective hERG potassium channel (Kv11.1) activator that increases peak tail hERG current of 111.1% at 10 uM in HEK293 cells; does not ot affect the voltage dependence and kinetics of gating parameters, and open conformation of the channel, also shows no major effect on I(Na), I(Ca,L), I(K1), and I(Ks); shortens the action potential duration and QT interval in arterially perfused rabbit ventricular wedge preparation, prevents action potential duration and QT prolongation caused by dofetilide at 3 uM.Heart Arrhythmia Discontinued.
-
体外实验PD-118057 (3 μM and 10 μM) specifically increases hERG current and inhibits action potential duration in guinea pig ventricular muscle in acute isolation of guinea pig cardiomyocytes.PD-118057 (10 μM) reverses the current inhibition induced by Dof and Mox without changing the "hump" shape of IKr current recorded by action potential clamp, and only slightly increases the peak value of the suppressed current.
-
体内实验——
-
同义词PD 118057 | PD118057
-
通路Cell Cycle/DNA Damage
-
靶点Potassium Channel
-
受体Potassium Channel
-
研究领域Cardiovascular Disease
-
适应症Heart Arrhythmia
化学信息
-
CAS Number313674-97-4
-
分子量386.272
-
分子式C21H17Cl2NO2
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 100 mg/mL (258.89 mM)
-
SMILESO=C(O)C1=CC=CC=C1NC2=CC=C(CCC3=CC=C(Cl)C(Cl)=C3)C=C2
-
化学全称2-{4-[2-(3,4-dichloro-phenyl)-ethyl]-phenylamino}-benzoic acid
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Zhou J, et al. Mol Pharmacol. 2005 Sep;68(3):876-84. Epub 2005 Jun 23.
2. Patel C, et al. Heart Rhythm. 2008 Apr;5(4):585-90.
3. Perry M, et al. Proc Natl Acad Sci U S A. 2009 Nov 24;106(47):20075-80.
产品手册
关联产品
-
Almitrine dimesylate
Almitrine dimesylate 选择性抑制 Ca2+ 依赖性 K+ 通道和大鼠化学感受器细胞中的 K+ 通道,用于治疗低氧性慢性肺部疾病。
-
SKA31
SKA 31 是 KCa3.1 和 KCa2 通道的激活剂(KCa3.1、KCa2.1 和 KCa2.2 的 EC50 分别为 260、2900、2900 nM)。
-
Ursodeoxycholic acid
熊二醇可减少胆固醇吸收并用于溶解胆结石。
021-51111890
购物车()
sales@molnova.cn

